In tumor-bearing mice, IL-17 promotes the formation of an immunosuppressive microenvironment by reversing the gene expression inhibition normally maintained by the mRNA decay factor AUF1, thus promoting tumor development and enhancing the activity of MDSCs (49, 50). The gene discussed is IL17A; the disease is neoplasm.